San Diego, CA — Illumina, Inc. (NASDAQ: ILMN) today announced it has signed a definitive agreement to acquire GenoLogics Life Sciences Software, a developer of industry-leading laboratory information management systems (LIMS) for life sciences organizations. The acquisition strengthens the industry-leading portfolio of Illumina genetic analysis solutions."The acquisition of GenoLogics demonstrates Illumina's commitment to drive the adoption of sequencing in new markets and improve the genomic information workflow," said Francis deSouza, President of Illumina. "Adding GenoLogics’ products to Illumina’s portfolio is another example of our continued commitment to bring innovative sample-to-answer solutions to research and clinical labs.”Read moreAuthor: GenoLogics and Illumina
